JP2010503690A5 - - Google Patents

Download PDF

Info

Publication number
JP2010503690A5
JP2010503690A5 JP2009528344A JP2009528344A JP2010503690A5 JP 2010503690 A5 JP2010503690 A5 JP 2010503690A5 JP 2009528344 A JP2009528344 A JP 2009528344A JP 2009528344 A JP2009528344 A JP 2009528344A JP 2010503690 A5 JP2010503690 A5 JP 2010503690A5
Authority
JP
Japan
Prior art keywords
amino
phenyl
cyclotetradec
diaza
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009528344A
Other languages
English (en)
Japanese (ja)
Other versions
JP5232786B2 (ja
JP2010503690A (ja
Filing date
Publication date
Priority claimed from US11/856,476 external-priority patent/US7517882B2/en
Application filed filed Critical
Publication of JP2010503690A publication Critical patent/JP2010503690A/ja
Publication of JP2010503690A5 publication Critical patent/JP2010503690A5/ja
Application granted granted Critical
Publication of JP5232786B2 publication Critical patent/JP5232786B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009528344A 2006-09-18 2007-09-18 タンパク質キナーゼ阻害剤として有用なピラゾロ(1,5−a)(1,3,5)トリアジン及びピラゾロ(1,5−a)ピリミジン誘導体 Expired - Fee Related JP5232786B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84531406P 2006-09-18 2006-09-18
US60/845,314 2006-09-18
US11/856,476 US7517882B2 (en) 2006-09-18 2007-09-17 Protein kinase inhibitors
US11/856,476 2007-09-17
PCT/US2007/020231 WO2008036277A1 (en) 2006-09-18 2007-09-18 Pyraz0l0(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2010503690A JP2010503690A (ja) 2010-02-04
JP2010503690A5 true JP2010503690A5 (enExample) 2010-11-04
JP5232786B2 JP5232786B2 (ja) 2013-07-10

Family

ID=39052753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009528344A Expired - Fee Related JP5232786B2 (ja) 2006-09-18 2007-09-18 タンパク質キナーゼ阻害剤として有用なピラゾロ(1,5−a)(1,3,5)トリアジン及びピラゾロ(1,5−a)ピリミジン誘導体

Country Status (11)

Country Link
US (2) US7517882B2 (enExample)
EP (1) EP2064214B1 (enExample)
JP (1) JP5232786B2 (enExample)
KR (1) KR101418619B1 (enExample)
CN (1) CN101522683B (enExample)
AU (1) AU2007297675B2 (enExample)
BR (1) BRPI0718459A2 (enExample)
CA (1) CA2663791C (enExample)
ES (1) ES2400450T3 (enExample)
TW (1) TWI472530B (enExample)
WO (1) WO2008036277A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517882B2 (en) * 2006-09-18 2009-04-14 Polaris Group Protein kinase inhibitors
WO2009126514A1 (en) * 2008-04-07 2009-10-15 Irm Llc Compounds and compositions as kinase inhibitors
KR20140078710A (ko) * 2011-09-30 2014-06-25 온코디자인 에스.에이. 거대고리 flt3 키나제 억제제
SG11201507493SA (en) * 2013-03-15 2015-10-29 Oncodesign Sa Macrocyclic salt-inducible kinase inhibitors
CN103570728B (zh) * 2013-11-12 2015-12-30 山东大学 一种取代吡唑并[1,5-a]嘧啶类衍生物及其制备方法与应用
EP3268000B1 (en) * 2015-03-09 2021-08-04 Aurigene Discovery Technologies Limited Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
SG11201900163PA (en) * 2016-07-28 2019-02-27 Tp Therapeutics Inc Macrocycle kinase inhibitors
SI3870579T1 (sl) 2018-10-22 2025-03-31 Alumis Inc. Inhibitorji tyk2 in njihova uporaba
CN113811534B (zh) * 2019-03-11 2024-10-29 阿鲁米斯公司 Tyk2抑制剂和其用途
US11780842B2 (en) * 2019-03-26 2023-10-10 Ventyx Biosciences, Inc. TYK2 pseudokinase ligands

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10255343B4 (de) * 2002-11-27 2006-09-07 Nad Ag N,N-Verbrückte, Stickstoff-Substituierte Carbacyclische Indolocarbazole als Proteinkinase-Inhibitoren
BRPI0410563B8 (pt) 2003-05-22 2021-05-25 Nerviano Medical Sciences Srl compostos de pirazol-quinazolina, seus processos de preparação e composições farmacêuticas
NZ551938A (en) * 2004-06-02 2010-07-30 Takeda Pharmaceutical Fused heterocyclic compound
US7517882B2 (en) * 2006-09-18 2009-04-14 Polaris Group Protein kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2010503690A5 (enExample)
JP2014526549A5 (enExample)
JP2010504344A5 (enExample)
JP2010241830A5 (enExample)
JP2014511869A5 (enExample)
JP2010532387A5 (enExample)
JP2011507849A5 (enExample)
JP2008501000A5 (enExample)
JP2010526814A5 (enExample)
JP2016517878A5 (enExample)
JP2010521483A5 (enExample)
JP2013501720A5 (enExample)
JP2016503786A5 (enExample)
JP2014508811A5 (enExample)
JP2017511794A5 (enExample)
JP2009531376A5 (enExample)
JP2008510770A5 (enExample)
JP2017532360A5 (enExample)
JP2012509263A5 (enExample)
JP2009523760A5 (enExample)
JP2019505541A5 (enExample)
JP2010538076A5 (enExample)
JP2008513498A5 (enExample)
JP2009504763A5 (enExample)
JP2012525431A5 (enExample)